Pediatric vaccine procurement policy: The monopsonist's problem

摘要

This paper addresses the issue of the pediatric vaccine industry's continuing viability from the perspective of the monopsonistic federal government. The monopsonistic market power of the federal government uniquely positions it to significantly influence the pediatric vaccine market by negotiating contractual agreements that increase the vaccine manufacturer's financial incentives to remain in the market. The monopsonist vaccine formulary pricing and purchasing problem (MVF3P) is introduced, which seeks pediatric vaccine prices and purchase quantities that ensure a birth cohort is fully immunized according to the recommended childhood immunization schedule at an overall minimum system cost while also ensuring that vaccine manufacturers each attain a reservation profit level. (29 refs.)